Publication | Closed Access
IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates
54
Citations
12
References
2015
Year
Based on our data comparing human IL-18 to current anti-VEGF-based therapy, clinical deployment of IL-18 for neovascular AMD has the potential to lead to a new adjuvant immunotherapy-based treatment for this severe form of central blindness.
| Year | Citations | |
|---|---|---|
Page 1
Page 1